COVID antiviral drugs

Subscribe to Breaking News Alerts

Biden tested positive for COVID again after taking Paxlovid. That was a known risk

Pfizer's Paxlovid pills are seen on display. The medicine received an emergency use authorization for COVID-19 last December. Joe Raedle/Getty Images hide caption

toggle caption

Joe Raedle/Getty Images

Politics

Biden tested positive for COVID again after taking Paxlovid. That was a known risk

July 21, 2022 • Paxlovid has been highly effective at reducing the risks of hospitalization and death, but some patients report a "Paxlovid rebound," in which the disease returns.

The COVID antiviral drugs are here but they're scarce. Here's what to know

Thomas Hansmann/Pfizer

Shots - Health News

The COVID antiviral drugs are here but they're scarce. Here's what to know

December 31, 2021 • Paxlovid and molnupiravir have been authorized for emergency use to keep COVID-19 patients out of the hospital, but don't expect to be able to go to your usual pharmacy and get them.

The COVID antiviral drugs are here but they're scarce. Here's what to know

Listen · 3:53 3:53

Download
Embed <iframe src="https://www.npr.org/player/embed/1069323181/1069739439" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Transcript